CN1332974C
(zh )
2007-08-22
抗雌激素甾族化合物、有关的药学组合物和使用方法
RU2007101304A
(ru )
2008-09-20
Модуляторы рецептора прогестерона, содержащие производные пиррол-оксиндола и применение
CN105873917B
(zh )
2021-08-10
含有吡啶基部分的非甾体类抗雄激素和选择性雄激素受体调节剂
EP1482925A1
(en )
2004-12-08
5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl!-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
JP2004513064A
(ja )
2004-04-30
癌の処置のためのアロマターゼインヒビターとしての、パクリタキセルおよびステロイド誘導体の使用
JP2009516747A5
(enExample )
2010-01-14
US20070238714A1
(en )
2007-10-11
Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
TWI234458B
(en )
2005-06-21
Inhibition of the growth factor dependency of tumor cells
JP6545266B2
(ja )
2019-07-17
17β‐HSD1抑制剤のプロドラッグ
AU2002215958B2
(en )
2006-08-17
Use of inhibitors of progesterone receptor for treating cancer
JP2009512633A5
(enExample )
2009-09-17
CA2501556A1
(en )
2004-04-29
Remedy for hormone-dependent cancer
AU2011345341B2
(en )
2016-10-20
Novel 19-nor-steroids and their use for treating progesterone-dependent conditions
KR20020086905A
(ko )
2002-11-20
노르에티스테론을 포함하는 남성 피임약 제형
JP2014500316A5
(enExample )
2014-10-09
TW200904451A
(en )
2009-02-01
Progesterone-receptor antagonist for use in BRCA alone or as combination with antiestrogen
US20080261929A1
(en )
2008-10-23
Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
WO2003073985A2
(en )
2003-09-12
New methods of using antiangiogenic agents
WO2005048956A2
(en )
2005-06-02
Estradiol-related compounds and methods of use as anti-tumor agents
Zelnak et al.
2018
Hormonal Therapy for Cancer
RU2008116571A
(ru )
2009-11-10
Новые с18 модифицированные ретростероиды в качестве модулятора рецептора прогестерона
JP2002543154A
(ja )
2002-12-17
2,1−ベンゾイソチアゾリン2,2−ジオキシドおよびプロゲステロン剤を含む避妊薬組成物
WO2006005633A1
(en )
2006-01-19
Combinations of pure anti-estrogen with aromatase inhibitors
HK1223609B
(zh )
2022-02-11
含有吡啶基部分的非甾体类抗雄激素和选择性雄激素受体调节剂